Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche's dealmakers at pRED will continue their global shopping spree in 2014
Fierce Biotech
Thursday, January 16, 2014 - 9:23am
tags:
Roche, pRED, R&D
The Carlyle Group Agrees to Acquire Johnson & Johnson’s Ortho-Clinical Diagnostics for $4.15 Billion
Marketwatch
Thursday, January 16, 2014 - 8:38am
tags:
JNJ, Carlyle, Ortho Clinical Diagnostics, diagnostics, M&A
Actavis to Quit China as Trouble Seen for Little Profit
Bloomberg
Thursday, January 16, 2014 - 8:17am
tags:
China, Actavis
BIO and Sanofi are pushing FDA to tweak drug shortage rule for vaccines
Fierce Vaccines
Thursday, January 16, 2014 - 8:16am
tags:
Sanofi, FDA, flu vaccines, vaccines
Mesoblast Is No Match For Pluristem's IP And Manufacturing
Seeking Alpha
Thursday, January 16, 2014 - 7:26am
tags:
Mesoblast, stem cells, Pluristem
Allergan rides high on patent backing for key drugs Lumigan and Restasis
Fierce Pharma
Thursday, January 16, 2014 - 6:54am
tags:
Allergan, patents, Lumigan, Restasis
Can OncoGenex Pharma (OGXI) Continue to Rise?
Yahoo/Zacks.com
Thursday, January 16, 2014 - 6:53am
tags:
OncoGenex
Oxford gene trial makes eye disease breakthrough
FT.com
Thursday, January 16, 2014 - 6:52am
tags:
Oxford BioMedica, choroideremia, gene therapy, blindness
Amarin says FDA delays decision on Vascepa trial design
Yahoo/Reuters
Thursday, January 16, 2014 - 6:50am
tags:
FDA, Vascepa, clinical trials
Drug Buyouts On The Rise — But Buyers Changing
Investors.com
Thursday, January 16, 2014 - 6:49am
tags:
M&A
FDA advisory panel backs Merck's blood clot-preventing drug
Reuters
Wednesday, January 15, 2014 - 5:50pm
tags:
FDA, advisory panels, Merck, Vorapaxar
Jury says Medtronic owes Edwards about $390M
Yahoo/AP
Wednesday, January 15, 2014 - 5:38pm
tags:
Medtronic, patents, Edwards Lifesciences, devices
J&J Said to Agree to Sell Ortho Unit to Carlyle for $4 Billion
Bloomberg
Wednesday, January 15, 2014 - 5:27pm
tags:
JNJ, M&A, diagnostics, Ortho Clinical Diagnostics, Carlyle
Intercept CEO says new drug could treat ‘next tsunami’ in liver disease
Marketwatch
Wednesday, January 15, 2014 - 5:21pm
tags:
Intercept Pharma, liver disease, nonalcoholic steatohepatitis, OCA
Alcobra's ADHD Program Moving To Pediatrics
Seeking Alpha
Wednesday, January 15, 2014 - 5:20pm
tags:
Alcobra, ADHD, pediatrics, MG01CI
Drug buyers sue Novo Nordisk over 'wrongful' delays to diabetes generic
Fierce Pharma
Wednesday, January 15, 2014 - 10:18am
tags:
pay-for-delay, Novo Nordisk, generics, diabetes, Cardinal Health
What's Merck Doing To Prevent More 'Missteps' With The FDA?
Forbes
Wednesday, January 15, 2014 - 10:11am
tags:
Merck, FDA
3 Biotechs Getting Plenty Of Attention From Investors
Seeking Alpha
Wednesday, January 15, 2014 - 10:09am
tags:
Depomed, Rexahn, Cambia, Zipsor, Gralise, Cangene, Emergent BioSolutions
Galectin announces IND filed to study GR-MD-02 in combination with Yervoy
Yahoo/Fly on the Wall
Wednesday, January 15, 2014 - 10:08am
tags:
GR-MD-02, Galectin, Yervoy, metastatic melanoma
Biogen, Celgene Lead 5 Top Large-Cap Drugmakers
Investors.com
Wednesday, January 15, 2014 - 10:06am
tags:
Biogen Idec, Celgene, Alexion, Actavis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.